Meeder Advisory Services’s Boston Scientific BSX Stock Holding History

Meeder Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.36M	Buy	37,648 +543	+1%	+$43.4K	0.1%	149
2025 Q4	$3.54M	Buy	37,105 +264	+0.7%	+$25.9K	0.15%	100
2025 Q3	$3.6M	Sell	36,841 -44	-0.1%	-$4.56K	0.17%	95
2025 Q2	$3.96M	Buy	36,885 +2,725	+8%	+$276K	0.21%	73
2025 Q1	$3.45M	Buy	34,160 +2,895	+9%	+$292K	0.21%	78
2024 Q4	$2.79M	Buy	31,265 +528	+2%	+$46.5K	0.17%	93
2024 Q3	$2.58M	Sell	30,737 -1,161	-4%	-$91.5K	0.17%	98
2024 Q2	$2.46M	Buy	31,898 +8,566	+37%	+$627K	0.17%	100
2024 Q1	$1.6M	Buy	23,332 +745	+3%	+$47.9K	0.16%	108
2023 Q4	$1.31M	Buy	22,587 +387	+2%	+$20.7K	0.15%	117
2023 Q3	$1.17M	Sell	22,200 -3,005	-12%	-$158K	0.15%	119
2023 Q2	$1.36M	Buy	25,205 +312	+1%	+$16.3K	0.15%	116
2023 Q1	$1.25M	Buy	24,893 +816	+3%	+$38.5K	0.14%	124
2022 Q4	$1.11M	Buy	+24,077	New	+$1.04M	0.14%	135

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Meeder Advisory Services's BSX Position: Q1 2026 in Review

Meeder Advisory Services increased its Boston Scientific (BSX) stake by 1.5% in Q1 2026, buying an estimated $43.4K and bringing the position to 37,648 shares worth $2.36M. The position accounts for 0.1% of the portfolio, ranked #149.

Meeder Advisory Services first reported a position in BSX in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.96M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Meeder Advisory Services held 37,648 shares of Boston Scientific worth $2.36M as of Q1 2026.
Meeder Advisory Services bought 543 Boston Scientific shares in Q1 2026, an estimated $43.4K.
Boston Scientific made up 0.1% of Meeder Advisory Services's portfolio in Q1 2026, its #149 holding.
Meeder Advisory Services first reported a position in Boston Scientific in Q4 2022 and has held it in 14 quarters since.
Meeder Advisory Services's Boston Scientific position peaked at $3.96M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.